The role of sentinel node biopsy in ductal carcinoma in situ of the breast

European Journal of Surgical Oncology

Volumn 35, Issue 1, 2009, Pages 43-47

  Polom, K ^a,b   Murawa, D ^a   Wasiewicz, J ^a   Nowakowski, W ^a   Murawa, P ^a,b  

^a GREATER POLAND CANCER CENTRE   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Core needle biopsy; Ductal carcinoma in situ (DCIS); Lymphadenectomy; Sentinel node biopsy (SNB)

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CARCINOMA IN SITU; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NEEDLE BIOPSY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; STEREOTACTIC BIOPSY;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; STEREOTAXIC TECHNIQUES; SURVIVAL ANALYSIS;

EID: 57549104378     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.07.007     Document Type: Article

References (23)

1. Ernster V.L., Ballard-Barbash R., Barlow W.E., Zheng Y., Weaver D.L., and Cutter G. Detection of ductal carcinoma in situ in woman undergoing screening mammography. J Natl Cancer Inst 94 (2002) 1546-1554
2. Silverstein M.J., Skinner K.A., and Lomis T.J. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 25 (2001) 767-772
3. Leonard G.D., and Swain S.M. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96 (2004) 906-920 [review]
4. Mittendorf E.A., Arciero C.A., Gutchell V., Hooke J., and Shriver C.D. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 62 (2005) 253-257
5. Crowe Jr. J.P., Patrick R.J., Rybicki L.A., et al. Does ultrasound core breast biopsy predict histologic Winding on excisional biopsy. Am J Surg 186 (2003) 397-409
6. Feldman S.M., Krag D.N., McNally R.K., Moor B.B., Weaver D.L., and Klein P. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 188 (1999) 248-254
7. Farkas E.A., Stolier A.J., Teng S.C., Bolton J.S., and Fuhrman G.M. An argument against routine sentinel node mapping for DCIS. Am Surg 70 (2004) 13-18
8. Wilkie C., White L., Dupont E., Cantor A., and Cox C.E. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 190 4 (2005) 563-566
9. Veronesi P., Intra M., Vento A.R., et al. Sentinel lymph node biopsy for localised ductal carcinoma in situ. Breast 14 (2005) 520-522
10. Katz A., Gage I., Evans S., Shaffer M., Fleury T., and Smith F.P. Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 191 (2006) 761-766
11. van Deurzen C.H., Hobbelink M.G., van Hillegersberg R., and van Diest P.J. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast. A review. Eur J Cancer 43 (2007) 993-1001
12. Mabry H., Giulino A.E., and Silverstein M.J. What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ. Am J Surg 192 (2006) 455-457
13. Bleiweiss I., Nagi C.S., and Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 24 (2006) 2013-2018
14. Cox C.E., Nguyen K., Gray R.J., Salud C., Ku N.N., and Dupont E. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?. Am Surg 67 6 (2001) 513-519
15. Yen T.W., Hunt K.K., Ross M.I., et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200 (2005) 516-526
16. Huo L., Sneige N., Hunt K.K., Albarracin C.T., Lopez A., and Resetkova E. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 107 (2006) 1760-1768
17. Jackman R.J., Burbank F., Parker S.H., et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 218 (2001) 497-502
18. Goyal A., Douglas-Jones A., Monypenny I., Sweetland H., Stevens G., and Mansel R.E. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat 98 (2006) 311-314
19. Lee C.H., Carter D., Philpotts L.E., et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy can invasion be predicted?. Radiology 217 (2000) 466-470
20. Hoorntje L.E., Schipper M.E., Peeters P.H., Bellot F., Storm R.K., and Borel Rinkes I.H. The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma in situ: causes of ductal carcinoma in situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 10 (2003) 748-753
21. Renshaw A.A. Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med 126 1 (2002) 39-41
22. Pandelidis S., Heilman D., Jones D., Stough K., Trapeni J., and Suliman Y. Accuracy of 11 gauge vacuum-assisted core biopsy of mammographic breast lesions. Ann Surg Oncol 20 (2003) 43-47
23. Dillon M.F., McDermott E.W., Quinn C.M., O'Doherty A., O'Higgins N., and Hill A.D.K. Predictors of invasive disease in breast cancer when core needles biopsy demonstrates DCIS only. J Surg Oncol 93 (2006) 559-563